Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.010 GeneticVariation phenotype BEFREE Among the polymorphisms studied, only IL1β (-511C>T) was associated with dizziness, (p = 0.01), suggesting that IL1β may be related to hypotensive episodes and increased vascular permeability. 27228225 2018
Entrez Id: 27342
Gene Symbol: RABGEF1
RABGEF1
0.010 AlteredExpression phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 43
Gene Symbol: ACHE
ACHE
0.010 AlteredExpression phenotype BEFREE Abnormal serum AChE levels associated with pesticide exposure are associated with AChE levels and symptoms such as coughing, being tired, dizziness, and dry skin and irritation. 30047860 2018
Entrez Id: 1577
Gene Symbol: CYP3A5
CYP3A5
0.010 Biomarker phenotype BEFREE Women and CYP3A5*1/*1 subjects showed more often dizziness (p = 0.034; p = 0.009). 29325225 2018
Entrez Id: 56731
Gene Symbol: SLC2A4RG
SLC2A4RG
0.010 Biomarker phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 2915
Gene Symbol: GRM5
GRM5
0.010 Biomarker phenotype BEFREE Adverse events incidence was higher with mGluR5 antagonists than with placebo, especially at the expense of increased dizziness (16.3 vs. 4.3%), visual hallucination (10.1 vs. 1.1%), or fatigue (10.1 vs. 4.8%). 30271338 2018
Entrez Id: 9181
Gene Symbol: ARHGEF2
ARHGEF2
0.010 Biomarker phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
0.010 GeneticVariation phenotype BEFREE The aim of this meta-analysis is to identify the predictive strength in the current literature of OPRM1-A118G polymorphism to postoperative anesthetic reactions, including nausea, vomiting, pruritus and dizziness. 30323865 2018
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.010 GeneticVariation phenotype BEFREE Conversely, LRRK2 G2019S carrier status significantly associated with reporting of milder daily symptoms of lightheadedness and several differences were observed at a false discovery rate < 0.1, including increased reporting of changes in walking as an initial symptom of disease, decreased reporting of lightheadedness upon standing, and milder symptoms related to daily functioning. 30154511 2018
Entrez Id: 5906
Gene Symbol: RAP1A
RAP1A
0.010 AlteredExpression phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.010 GeneticVariation phenotype BEFREE Moreover, Symptoms like asthma (25%), cough (76.67%), dizziness (36.67%), eye irritation (88.33%), and shortness of breath (43.33%) were highly prevalent among biomass users than in LPG users. 29940511 2018
Entrez Id: 54386
Gene Symbol: TERF2IP
TERF2IP
0.010 AlteredExpression phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 2740
Gene Symbol: GLP1R
GLP1R
0.010 Biomarker phenotype BEFREE Ranking probability analysis indicated that GLP-1 RAs may have the greatest risk of both dizziness and headache among the nine treatments (22.5% and 23.4%, respectively), whereas DPP-4Is were in the middle (46.2% and 45.0%, respectively). 31788342 2019
Entrez Id: 79813
Gene Symbol: EHMT1
EHMT1
0.010 Biomarker phenotype BEFREE Ranking probability analysis indicated that GLP-1 RAs may have the greatest risk of both dizziness and headache among the nine treatments (22.5% and 23.4%, respectively), whereas DPP-4Is were in the middle (46.2% and 45.0%, respectively). 31788342 2019
Entrez Id: 80025
Gene Symbol: PANK2
PANK2
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 6448
Gene Symbol: SGSH
SGSH
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 9043
Gene Symbol: SPAG9
SPAG9
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 64374
Gene Symbol: SIL1
SIL1
0.010 Biomarker phenotype BEFREE To study PNS vulnerability in MSS, intramuscular nerves fibres from MSS patients and from SIL1-deficient mice (woozy) as well as sciatic nerves and neuromuscular junctions (NMJ) from these mice have been investigated via transmission electron microscopic and immunofluorescence studies accompanied by transcript studies and unbiased proteomic profiling. 30468864 2019
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.010 Biomarker phenotype BEFREE Accordingly, DB is often underdiagnosed or misdiagnosed, given the similarity of its associated symptoms (dyspnea, tachycardia, and dizziness) to those of other common cardiopulmonary diseases such as COPD and asthma. 30758427 2019
Entrez Id: 9311
Gene Symbol: ASIC3
ASIC3
0.010 GeneticVariation phenotype BEFREE However, whether the genetic variants of <i>ASIC3</i> are associated with people who suffer dizziness and balance impairment after mTBI remained unknown. 30804886 2019
Entrez Id: 3094
Gene Symbol: HINT1
HINT1
0.010 Biomarker phenotype BEFREE We included patients 18 years of age or older, visiting the adult ED of a French university hospital for a new episode of dizziness evolving for less than 72 h. All patients underwent standardized physical examination (HINT [Head Impulse test, Nystagmus, test of skew deviation] maneuvers), copeptin and S-100b protein (PS100) measurement and injected brain imaging. 31387626 2019
Entrez Id: 2242
Gene Symbol: FES
FES
0.010 Biomarker phenotype BEFREE A sample of 662 79-year-olds (404 women, 258 men) were investigated with questions regarding dizziness, previous falls and falls efficacy [estimated according to the falls efficacy scale Swedish version (FES (S))]. 31489596 2019
Entrez Id: 7170
Gene Symbol: TPM3
TPM3
0.010 Biomarker phenotype BEFREE While TRK inhibitors have a favourable overall safety profile, select on-target adverse events, including weight gain, dizziness/ataxia and paraesthesias, are occasionally observed and should be monitored in the clinic. 31738426 2019
Entrez Id: 8864
Gene Symbol: PER2
PER2
0.010 Biomarker phenotype BEFREE This was an interventional study using medical records to collect data for acute dizziness presentations before (period 1, 2012-2014) and after (period 2, 2016-2017) the implementation of a management algorithm. 31098875 2019
Entrez Id: 3769
Gene Symbol: KCNJ13
KCNJ13
0.010 Biomarker phenotype BEFREE Finally, we propose that SVD-mediated dysregulation of cerebral blood pressure is linked to dizziness during standing and walking in elderly patients with "unexplained" dizziness. 31239134 2019